
TL;DR: A 2026 longitudinal study in Journal of Korean Medical Science found that self-reported phobic anxiety on the Symptom Checklist-90-Revised helped predict 2-month depression treatment response even when baseline clinician-rated depression and anxiety sco…
Read article ↗
TL;DR: A 2026 review in Brain Medicine found mixed randomized-trial evidence for creatine monohydrate as an add-on depression treatment: 2 of 5 trials showed symptom benefits, while 3 did not find a clear advantage. Key Findings Five randomized trials were rev…
Read article ↗
TL;DR: A 2026 systematic review and meta-analysis in Pain Medicine found that Medicaid enrollment and preoperative benzodiazepine use had the largest pooled associations with new persistent opioid use after surgery among opioid-naive US adults. Key Findings 27…
Read article ↗
TL;DR: A 2026 study in BMC Psychiatry found that structural MRI of the cerebellum separated first-episode bipolar depression from unipolar depression with 76.3% exploratory model accuracy, mainly because several cerebellar gray-matter regions were smaller in b…
Read article ↗
TL;DR: A 2026 MRI preprint on medRxiv found that patients with catatonia were less likely to have a left paracingulate sulcus (PCS), a stable anterior cingulate cortex fold, than psychiatric patients without catatonia. Key Findings 523 MRI scans: Researchers c…
Read article ↗
TL;DR: A 2026 population-based study in The Canadian Journal of Psychiatry found that early-life adversity scores were linked to higher group-level mental health risk but performed poorly for identifying which Canadian adults had anxiety, mood disorders, subst…
Read article ↗
TL;DR: A 2026 cross-sectional study in PLOS One found that euthymic bipolar disorder patients with early systematic antidepressant treatment had higher negative affect and higher attentional, non-planning, and total impulsivity scores than matched patients wit…
Read article ↗
A new study published in the journal Mædica – a Journal of Clinical Medicine compared the antidepressant effects of modafinil versus citalopram for treating major depressive disorder (MDD). The medications were equally effective at reducing depressive symptoms…
Read article ↗